Sodium Butyrate For Improving Cognitive Function In Schizophrenia

Summary

The purpose of this grant is to evaluate the efficacy of sodium butyrate as a novel treatment for cognitive deficits in schizophrenia (SZ). The aims will be to evaluate its effects on improving symptoms and functioning in SZ, and the relationship of the drug's clinical effects to epigenetic and inflammation related biochemical changes.

Timeline

Start

2017-06-01

Primary completion

2019-12

Completion

2020-02

Outcome

Outcome not reported

Stopped (Business): “sponsor withdrew the funds because the smell of sodium butyrate made blinding impossible”

Drugs

Indications